Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 3
2004 1
2005 1
2006 2
2010 1
2015 1
2019 3
2020 3
2021 2
2022 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Trends in innovative drug development in China.
Su X, Wang H, Zhao N, Wang T, Cui Y. Su X, et al. Among authors: wang h. Nat Rev Drug Discov. 2022 Oct;21(10):709-710. doi: 10.1038/d41573-022-00077-3. Nat Rev Drug Discov. 2022. PMID: 35513561 No abstract available.
Digitalized Adaptation of Oncology Trials during and after COVID-19.
Li G, Yin C, Zhou Y, Wang T, Chen J, Liu Y, Chen T, Wang H, Zhang L, Chen X. Li G, et al. Among authors: wang h. Cancer Cell. 2020 Aug 10;38(2):148-149. doi: 10.1016/j.ccell.2020.06.018. Epub 2020 Jul 6. Cancer Cell. 2020. PMID: 32634378 Free PMC article. No abstract available.
Erratum: Wang, H., et al. The Relationship between Parental Perception of Neighborhood Collective Efficacy and Physical Violence by Parents against Preschool Children: A Cross-Sectional Study in a County of China. Int. J. Environ. Res. Public Health 2019, 16, 2305.
Wang H, Chen J, Lyu L. Wang H, et al. Int J Environ Res Public Health. 2019 Dec 24;17(1):145. doi: 10.3390/ijerph17010145. Int J Environ Res Public Health. 2019. PMID: 31878185 Free PMC article.
New era of drug innovation in China.
Ye X, Wang Q, Wang H. Ye X, et al. Among authors: wang h. Acta Pharm Sin B. 2019 Sep;9(5):1084-1085. doi: 10.1016/j.apsb.2019.06.002. Epub 2019 Jun 18. Acta Pharm Sin B. 2019. PMID: 31649856 Free PMC article. No abstract available.
Pathological response and predictive role of tumour-infiltrating lymphocytes in HER2-positive early breast cancer treated with neoadjuvant pyrotinib plus trastuzumab and chemotherapy (Panphila): a multicentre phase 2 trial.
Liu Z, Wang C, Chen X, Zhu J, Sun X, Xia Q, Lu Z, Qiao J, Zhou Y, Wang H, Wang Y, Yan M. Liu Z, et al. Among authors: wang h. Eur J Cancer. 2022 Apr;165:157-168. doi: 10.1016/j.ejca.2022.01.022. Epub 2022 Feb 27. Eur J Cancer. 2022. PMID: 35235873 Free article. Clinical Trial.
Real-World First-Line Treatment Patterns and Outcomes in Hormone Receptor-Positive Advanced Breast Cancer Patients: A Multicenter, Retrospective Study in China.
Chen Z, Ouyang Q, Wang Y, Wang J, Wang H, Wu X, Zhang P, Huang J, Zheng Y, Cao W, Shao X, Xie N, Tian C, Liang H, Wang C, Zhang Y, Ren D, Wang X. Chen Z, et al. Among authors: wang h. Front Oncol. 2022 Mar 3;12:829693. doi: 10.3389/fonc.2022.829693. eCollection 2022. Front Oncol. 2022. PMID: 35311126 Free PMC article.
24 results